Artiva Biotherapeutics, Inc.
(NASDAQ: ARTV)
Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.
3.416
-0.359
(-9.51%)
Range
3.400 - 3.800
(11.76%)
Open
3.740
Previous Close
3.775
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
59,939
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 02:07.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
